drugset / Trial / NCT00736229

Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients

NCT00736229

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy of intravenous Exenatide therapy in hyperglycemic patients admitted to the coronary intensive care unit.

Timeline

Start
2008-08
Primary completion
2011-06
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide 0.025 ug Intravenous